| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 672694 | 47396 | PENILEVEL RETARD 1.000.000 U.I. | PENILEVEL RETARD 1.000.000 U.I. , 1 vial + 1 ampolla de disolvente | 200.000 UI/600.000 UI/200.000 UI | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1969-03-01 | 1 | 1 | 1 | 1969-03-01 | 2011-03-29 | 0 | 2011-09-21 | 819177, 653435 | View Edit Delete | |||||||||||
| 672084 | 33411 | GENOXAL 200 mg POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN | GENOXAL 200 mg POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/33411/33411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/33411/33411_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 1960-02-01 | 1 | 1 | 1 | 1960-02-01 | 2011-03-10 | 0 | 2011-07-01 | 876383, 663200 | View Edit Delete | |||||||||||
| 674127 | 96011001 | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 2 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96011001/96011001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96011001/96011001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30180 | BAXTER S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673954 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 15 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 674119 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 30 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 672240 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 viales de 25 mg | 25 mg | 45 | 20 | 34 | 20 viales de 25 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672241 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 viales de 100 mg | 100 mg | 45 | 5 | 34 | 5 viales de 100 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673413 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673414 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 7 ml | 20 mg/ml inyectable 7 ml | 45 | 1 | 34 | 1 vial de 7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673420 | 72637 | IMIPENEM/CILASTATINA AUROVITAS 500 mg/500 mg POLVO PARA SOLUCION PARA PERFUSION EFG | IMIPENEM/CILASTATINA AUROVITAS 500 mg/500 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 10 viales | 500 mg/500 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72637/72637_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72637/72637_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-02-02 | 1 | 1 | 1 | 2011-02-02 | 2011-02-02 | 1 | 2013-03-07 | View Edit Delete | ||||||||||||
| 673372 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete | ||||||||||||
| 673770 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 40 ml | 5 mg/ml inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2011-03-16 | 1 | 2011-06-20 | View Edit Delete | ||||||||||||
| 672501 | 61490 | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 5 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61490/61490_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61490/61490_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672519 | 61489 | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 2 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61489/61489_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61489/61489_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672527 | 61488 | ULTIVA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 1 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61488/61488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61488/61488_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 673178 | 61452 | TOMUDEX 2 MG POLVO PARA SOLUCION PARA PERFUSION | TOMUDEX 2 MG POLVO PARA SOLUCION PARA PERFUSION , 1 vial | 2 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61452/61452_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61452/61452_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20471 | PFIZER S.L. | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1997-03-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 675206 | 72862 | ROCURONIO TAMARANG 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | ROCURONIO TAMARANG 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG , 10 viales de 5 ml | 10 mg/ml inyectable 5 ml | 45 | 10 | 34 | 10 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72862/72862_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72862/72862_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 43981 | TAMARANG S.A. | 2011-05-16 | 1 | 1 | 1 | 2011-05-16 | 2011-05-16 | 1 | 2013-01-25 | View Edit Delete | ||||||||||||
| 674945 | 62641 | CEFTRIAXONA NORMON 1000 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 1000 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62641/62641_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62641/62641_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674952 | 62640 | CEFTRIAXONA NORMON 500 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 500 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 500 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62640/62640_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62640/62640_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674960 | 62639 | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 250 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62639/62639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62639/62639_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete |
Page 267 of 1035, showing 20 records out of 20689 total, starting on record 5321, ending on 5340